542724 Stock Overview
Murae Organisor Limited engages in the manufacture, marketing, trading, and distribution of a range of pharmaceutical formulation products in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Murae Organisor Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1.66 |
| 52 Week High | ₹3.10 |
| 52 Week Low | ₹0.90 |
| Beta | -0.36 |
| 1 Month Change | 5.73% |
| 3 Month Change | -18.23% |
| 1 Year Change | -23.85% |
| 3 Year Change | -75.50% |
| 5 Year Change | n/a |
| Change since IPO | -53.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| 542724 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.8% | 1.4% | 2.8% |
| 1Y | -23.9% | 57.2% | 46.6% |
Price Volatility
| 542724 volatility | |
|---|---|
| 542724 Average Weekly Movement | 7.3% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 542724's share price has been volatile over the past 3 months.
Volatility Over Time: 542724's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | n/a | www.earumpharma.com |
Murae Organisor Limited engages in the manufacture, marketing, trading, and distribution of a range of pharmaceutical formulation products in India. The company offers anti-biotic, anti-malarial, anti-allergic, anti-cold, analgesic/anti-pyretic, anti inflammatory, dermatology products, cerebral activator, neurological, gastro intestinal, gynecology drugs, steroids, calcium, multivitamins, anti-oxidants, and injections. It provides various pharmaceutical formulation products approximately 120 products are marketed under its brand name.
Murae Organisor Limited Fundamentals Summary
| 542724 fundamental statistics | |
|---|---|
| Market cap | ₹410.21m |
| Earnings (TTM) | -₹9.02m |
| Revenue (TTM) | ₹40.76m |
10.1x
P/S Ratio-45.5x
P/E RatioIs 542724 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 542724 income statement (TTM) | |
|---|---|
| Revenue | ₹40.76m |
| Cost of Revenue | ₹30.44m |
| Gross Profit | ₹10.32m |
| Other Expenses | ₹19.34m |
| Earnings | -₹9.02m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.037 |
| Gross Margin | 25.32% |
| Net Profit Margin | -22.14% |
| Debt/Equity Ratio | 4.6% |
How did 542724 perform over the long term?
See historical performance and comparison